白癜风复色率计算机辅助评估:治疗疗效意义回顾性研究
计算机辅助系统评估显示边缘色素沉着模式复色率72%,高于中央非毛囊模式45%;男性平均复色率0.37略高于女性0.33;0-20岁组平均复色率最高0.41,61-80岁组最低0.25;多次随访中边缘模式最常见(60%),平均复色率40%。
要点
- 边缘色素沉着模式复色率72%,高于中央非毛囊模式45%。
- 0-20岁组平均复色率最高0.41,61-80岁组最低0.25。
- 多次随访中边缘模式最常见(60%),平均复色率40%。
核心结论
- 计算机辅助系统可评估白癜风患者复色率,边缘色素沉着模式复色率高于中央非毛囊模式。
主要发现
- 边缘色素沉着模式复色率为72%,中央非毛囊模式为45%。
- 男性平均复色率0.37,女性0.33。
- 0-20岁组平均复色率最高0.41,61-80岁组最低0.25。
- 多次随访中边缘模式最常见(60%),平均复色率40%。
临床怎么用
- 可利用计算机辅助系统客观评估白癜风复色率,辅助监测治疗疗效。
- 评估复色时应考虑色素沉着模式、性别和年龄对复色率的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Precise evaluation of repigmentation in vitiligo patients is crucial for monitoring treatment efficacy and enhancing patient satisfaction. This study aimed to develop a computer-aided system for assessing repigmentation rates in vitiligo patients, providing valuable insights for clinical practice. A retrospective study was conducted at the Dermatology Department of Shenzhen People's Hospital between June 2019 and November 2022. Pre- and post-treatment images of vitiligo lesions under Wood's lamp were collected, involving 833 participants stratified by sex, age, and pigmentation patterns. Our results demonstrated that the marginal pigmentation pattern exhibited a higher repigmentation rate of 72% compared with the central non-follicular pattern at 45%. Males had a slightly higher average repigmentation rate of 0.37 in comparison to females at 0.33. Among age groups, individuals aged 0-20 years showed the highest average repigmentation rate at 0.41, while the oldest age group (61-80 years) displayed the lowest rate at 0.25. Analysis of multiple visits identified the marginal pattern as the most prevalent (60%), with a mean repigmentation rate of 40%. This study introduced a computational system for evaluating vitiligo repigmentation rates, enhancing our comprehension of patient responses, and ultimately contributing to enhanced clinical care.
引用
- Wang Z, Hu H, Ou Y, et al. Computer-Aided Assessment of Repigmentation Rates in Vitiligo Patients: Implications for Treatment Efficacy - A Retrospective Study. J Invest Dermatol. 2024. PMID: 38909840. doi:10.1016/j.jid.2024.05.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。